Zujewski J - Search Results

1

Sentinel lymph node biopsy in the management of ductal carcinoma in situ.

Zujewski J, Eng-Wong J. Zujewski J, et al. Clin Breast Cancer. 2005 Aug;6(3):216-22. doi: 10.3816/CBC.2005.n.023. Clin Breast Cancer. 2005. PMID: 16137431 Review.

2

A pilot study of dose intense doxorubicin and cyclophosphamide followed by infusional paclitaxel in high-risk primary breast cancer.

Zujewski JA, Eng-Wong J, O'Shaughnessy J, Venzon D, Chow C, Danforth D, Kohler DR, Cusack G, Riseberg D, Cowan KH. Zujewski JA, et al. Breast Cancer Res Treat. 2003 Sep;81(1):41-51. doi: 10.1023/A:1025421416674. Breast Cancer Res Treat. 2003. PMID: 14531496 Clinical Trial.

3

Raloxifene and its role in breast cancer prevention.

Eng-Wong J, Zujewski JA. Eng-Wong J, et al. Among authors: zujewski ja. Expert Rev Anticancer Ther. 2004 Aug;4(4):523-32. doi: 10.1586/14737140.4.4.523. Expert Rev Anticancer Ther. 2004. PMID: 15270657 Review.

4

Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer.

Faupel-Badger JM, Prindiville SA, Venzon D, Vonderhaar BK, Zujewski JA, Eng-Wong J. Faupel-Badger JM, et al. Among authors: zujewski ja. Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1153-8. doi: 10.1158/1055-9965.EPI-05-0898. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16775175 Clinical Trial.

5

Current NCI-sponsored Cooperative Group trials of endocrine therapies in breast cancer.

Eng-Wong J, Zujewski JA. Eng-Wong J, et al. Among authors: zujewski ja. Cancer. 2008 Feb 1;112(3 Suppl):723-729. doi: 10.1002/cncr.23188. Cancer. 2008. PMID: 18072276 Free article.

6

Recruitment to a physical activity intervention study in women at increased risk of breast cancer.

Korde LA, Micheli A, Smith AW, Venzon D, Prindiville SA, Drinkard B, Sebring N, Smith MD, Zujewski JA, Eng-Wong J. Korde LA, et al. Among authors: zujewski ja. BMC Med Res Methodol. 2009 Apr 27;9:27. doi: 10.1186/1471-2288-9-27. BMC Med Res Methodol. 2009. PMID: 19397816 Free PMC article.

7

A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancer.

Lebowitz PF, Eng-Wong J, Swain SM, Berman A, Merino MJ, Chow CK, Venzon D, Zia F, Danforth D, Liu E, Zujewski J. Lebowitz PF, et al. Among authors: zujewski j. Clin Cancer Res. 2004 Oct 15;10(20):6764-9. doi: 10.1158/1078-0432.CCR-04-0976. Clin Cancer Res. 2004. PMID: 15501952 Clinical Trial.

8

A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer.

Lebowitz PF, Eng-Wong J, Widemann BC, Balis FM, Jayaprakash N, Chow C, Clark G, Gantz SB, Venzon D, Zujewski J. Lebowitz PF, et al. Among authors: zujewski j. Clin Cancer Res. 2005 Feb 1;11(3):1247-52. Clin Cancer Res. 2005. PMID: 15709195 Clinical Trial.

9

Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.

Eng-Wong J, Hursting SD, Venzon D, Perkins SN, Zujewski JA. Eng-Wong J, et al. Among authors: zujewski ja. Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1468-73. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14693739 Clinical Trial.

10

Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer.

Eng-Wong J, Orzano-Birgani J, Chow CK, Venzon D, Yao J, Galbo CE, Zujewski JA, Prindiville S. Eng-Wong J, et al. Among authors: zujewski ja. Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1696-701. doi: 10.1158/1055-9965.EPI-07-2752. Epub 2008 Jun 26. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18583470 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page